Platelet Function Tests

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Platelet Function Tests trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingEarly Phase 1

NCT06933056

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

This study will identify the potential benefits of regulating platelet activation with sotagliflozin compared to other FDA-approved drugs known to limit platele…

United States20 participantsStarted 2025-09-02

Treatment: Sotagliflozin (SOTA) followed by 3 drugs in a random order, Aspirin followed by 3 drugs in a random order

All recent trials (70 shown)

Active — Not RecruitingPhase 4

NCT04654052

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

The objective of the study is to establish a de-scaling strategy of P2Y12 inhibitors (P2Y12 i) with a decrease in hemorrhagic events without increasing ischemic…

Spain634 participantsStarted 2021-07-02

Treatment: Clopidogrel, Previous treatment

CompletedNot Applicable

NCT01314560

Study of the Pathophysiological Mechanisms Involved in Bleeding Events

Lowe syndrome is associated with mutations in the OCRL1 gene, which encodes OCRL1, a phosphatidylinositol-4, 5-bisphosphate (PtdIns(4, 5)P (2))5-phosphatase. Pt…

France30 participantsStarted 2009-02

Treatment: Blood sample

Platelet Function Tests

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

All recent trials (70 shown)

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

Study of the Pathophysiological Mechanisms Involved in Bleeding Events

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

All recent trials (70 shown)

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

Study of the Pathophysiological Mechanisms Involved in Bleeding Events

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Hematological Disorders in EHPVO Patients

The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.

Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on Ticagrelor

Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovaria…

Magnesium and Platelet Function Testing

Genotype Information and Functional Testing Study

Bone Marrow Suppression and Recovery During Radionuclide Treatment

Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profil…

Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Will…

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Pharmacodynamic Study of Cilostazol in Healthy Volunteers

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagent…

Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients

Risk Stratification Post TAVI Using TEG

The Evaluation of Hemostasis in Hospitalized COVID-19 Patients